BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37006060)

  • 21. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir.
    Nagpal A; Verma S; Shah R; Bhat GR; Bhat A; Bakshi D; Sharma B; Kaul S; Kumar R
    Indian J Cancer; 2020; 57(2):187-189. PubMed ID: 32167073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.
    Spurdle AB; Goodwin B; Hodgson E; Hopper JL; Chen X; Purdie DM; McCredie MR; Giles GG; Chenevix-Trench G; Liddle C
    Pharmacogenetics; 2002 Jul; 12(5):355-66. PubMed ID: 12142725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MassArray analysis of genomic susceptibility variants in ovarian cancer.
    Verma S; Sharma I; Sharma V; Bhat A; Shah R; Bhat GR; Sharma B; Bakshi D; Nagpal A; Wakhloo A; Bhat A; Kumar R
    Sci Rep; 2020 Dec; 10(1):21101. PubMed ID: 33273524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common genetic variants on 3q28 contribute to non-small cell lung cancer susceptibility: evidence from 10 case-control studies.
    Jin YX; Jiang GN; Zheng H; Duan L; Ding JA
    Mol Genet Genomics; 2015 Apr; 290(2):573-84. PubMed ID: 25344291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
    Hughes DJ; Ginolhac SM; Coupier I; Corbex M; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Maugard C; Olschwang S; Yannoukakos D; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Szabo C; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):265-7. PubMed ID: 15668505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
    Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
    J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.
    Webb PM; Hopper JL; Newman B; Chen X; Kelemen L; Giles GG; Southey MC; Chenevix-Trench G; Spurdle AB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):319-23. PubMed ID: 15734952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP63-truncating variants cause isolated premature ovarian insufficiency.
    Tucker EJ; Jaillard S; Grover SR; van den Bergen J; Robevska G; Bell KM; Sadedin S; Hanna C; Dulon J; Touraine P; Sinclair AH
    Hum Mutat; 2019 Jul; 40(7):886-892. PubMed ID: 30924587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
    Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
    Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor].
    Du ZG; Wang LY; Zhou Y; Wan HY; Liang FQ; Lyu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):827-832. PubMed ID: 30107717
    [No Abstract]   [Full Text] [Related]  

  • 36. SNPs at TP63 gene was specifically associated with right-side cleft lip in Han Chinese population.
    Yin B; Shi JY; Lin YS; Shi B; Jia ZL
    Oral Dis; 2021 Apr; 27(3):559-566. PubMed ID: 32687624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Kaufman B; Laitman Y; Ziv E; Hamann U; Torres D; Lahad EL; Beeri R; Renbaum P; Jakubowska A; Lubinski J; Huzarski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Sprudle AB; Chenevix-Trench G; Simard J; Easton DF; Antonis A; Szabo C; Friedman E
    Breast Cancer Res Treat; 2011 Apr; 126(2):521-7. PubMed ID: 20798986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.
    Dai ZJ; Liu XH; Kang HF; Wang XJ; Jin TB; Zhang SQ; Feng T; Ma XB; Wang M; Feng YJ; Liu K; Xu P; Guan HT
    Medicine (Baltimore); 2016 Feb; 95(6):e2801. PubMed ID: 26871844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
    Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
    Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis.
    Mun MJ; Kim TH; Hwang JY; Jang WC
    Maturitas; 2015 Jun; 81(2):256-65. PubMed ID: 25882760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.